https://www.selleckchem.com/peptide/pmx-205.html
The randomization sequence is blinded to the investigators and allocation is disclosed only after valid consent. Ambulatory blood pressure measurements will be performed at baseline, 3-month and 12-month. The primary outcome is proportion of participants with ND at 3-months; secondary outcomes include proportion of participants with ND at 12-months, absolute BP values at 3-month and 12-month. Exercise level will be detected by validated questionnaire and compared between two arms at 3-month and 12-month. The trial will examine the effica
Gefällt mir
Kommentar
Teilen
